Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atrayee Basu-Mallick

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Diagnostic Pathology|April 11, 2023
A rare metastatic mesenteric malignant PEComa with TSC2 mutation treated with palliative surgical resection and nab-sirolimus: a case reportLuke Meredith, Timothy Chao, Avinoam Nevler, et al.
Cancers|December 24, 2021
The Effects of Physical Activity on Cancer Patients Undergoing Treatment with Immune Checkpoint Inhibitors: A Scoping ReviewAmy L Shaver, Swapnil Sharma, Nikita Nikita, et al.
BMJ Open|July 21, 2022
Understanding the role of sex on outcomes for the cancer patient undergoing treatment with immune checkpoint inhibitors: a scoping review protocolAmy L Shaver, Nikita Nikita, Swapnil Sharma, et al.
Clinical Colorectal Cancer|January 31, 2012
PTEN gene expression and mutations in the PIK3CA gene as predictors of clinical benefit to anti-epidermal growth factor receptor antibody therapy in patients with KRAS wild-type metastatic colorectal cancerArjun Sood, Danielle McClain, Radhashree Maitra, et al.
JAAD Case Reports|May 13, 2026
Multidisciplinary care in the management of pleomorphic dermal sarcoma: A single-center case series and reviewJaanvi Mehta, Leena Wardeh, Jayson Suriano, et al.
American Journal of Clinical Pathology|March 1, 2023
TOMM20 as a Potential Prognostic Biomarker in Chordoma: Results From a High-Volume, Single-Center StudyIda Micaily, Sherry Lee, Atrayee Basu Mallick, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 17, 2018
A Routine Laboratory Data-Based Model for Predicting Recurrence After Curative Resection of Stage II Colorectal CancerZhong Ye, Chun Wang, Limin Guo, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|September 13, 2020
Translocase of the outer mitochondrial membrane complex subunit 20 (TOMM20) facilitates cancer aggressiveness and therapeutic resistance in chondrosarcomaMegan E Roche, Zhao Lin, Diana Whitaker-Menezes, et al.
Molecular Oncology|February 25, 2025
TOMM20 as a driver of cancer aggressiveness via oxidative phosphorylation, maintenance of a reduced state, and resistance to apoptosisRanakul Islam, Megan E Roche, Zhao Lin, et al.
Cancer Research Communications|March 27, 2023
A Phase II Study Investigating Cabozantinib in Patients with Refractory Metastatic Colorectal Cancer (AGICC 17CRC01)Aaron J Scott, Atrayee Basu Mallick, Efrat Dotan, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Diagnostic Pathology|April 11, 2023
A rare metastatic mesenteric malignant PEComa with TSC2 mutation treated with palliative surgical resection and nab-sirolimus: a case reportLuke Meredith, Timothy Chao, Avinoam Nevler, et al.
Cancers|December 24, 2021
The Effects of Physical Activity on Cancer Patients Undergoing Treatment with Immune Checkpoint Inhibitors: A Scoping ReviewAmy L Shaver, Swapnil Sharma, Nikita Nikita, et al.
BMJ Open|July 21, 2022
Understanding the role of sex on outcomes for the cancer patient undergoing treatment with immune checkpoint inhibitors: a scoping review protocolAmy L Shaver, Nikita Nikita, Swapnil Sharma, et al.
Clinical Colorectal Cancer|January 31, 2012
PTEN gene expression and mutations in the PIK3CA gene as predictors of clinical benefit to anti-epidermal growth factor receptor antibody therapy in patients with KRAS wild-type metastatic colorectal cancerArjun Sood, Danielle McClain, Radhashree Maitra, et al.
JAAD Case Reports|May 13, 2026
Multidisciplinary care in the management of pleomorphic dermal sarcoma: A single-center case series and reviewJaanvi Mehta, Leena Wardeh, Jayson Suriano, et al.
American Journal of Clinical Pathology|March 1, 2023
TOMM20 as a Potential Prognostic Biomarker in Chordoma: Results From a High-Volume, Single-Center StudyIda Micaily, Sherry Lee, Atrayee Basu Mallick, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 17, 2018
A Routine Laboratory Data-Based Model for Predicting Recurrence After Curative Resection of Stage II Colorectal CancerZhong Ye, Chun Wang, Limin Guo, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|September 13, 2020
Translocase of the outer mitochondrial membrane complex subunit 20 (TOMM20) facilitates cancer aggressiveness and therapeutic resistance in chondrosarcomaMegan E Roche, Zhao Lin, Diana Whitaker-Menezes, et al.
Molecular Oncology|February 25, 2025
TOMM20 as a driver of cancer aggressiveness via oxidative phosphorylation, maintenance of a reduced state, and resistance to apoptosisRanakul Islam, Megan E Roche, Zhao Lin, et al.
Cancer Research Communications|March 27, 2023
A Phase II Study Investigating Cabozantinib in Patients with Refractory Metastatic Colorectal Cancer (AGICC 17CRC01)Aaron J Scott, Atrayee Basu Mallick, Efrat Dotan, et al.
Pageof 3